Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases

BACKGROUND & AIMS: We aimed to identify biomarkers that might be used to predict responses of patients with inflammatory bowel diseases (IBD) to vedolizumab therapy. METHODS: We obtained biopsies from inflamed colon of patients with IBD who began treatment with vedolizumab (n = 31) or tumor necr...

Descripción completa

Detalles Bibliográficos
Autores principales: Verstockt, Bram, Verstockt, Sare, Veny, Marisol, Dehairs, Jonas, Arnauts, Kaline, Van Assche, Gert, De Hertogh, Gert, Vermeire, Séverine, Salas, Azucena, Ferrante, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders for the American Gastroenterological Association 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196933/
https://www.ncbi.nlm.nih.gov/pubmed/31446181
http://dx.doi.org/10.1016/j.cgh.2019.08.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196933/
https://www.ncbi.nlm.nih.gov/pubmed/31446181
http://dx.doi.org/10.1016/j.cgh.2019.08.030

Ejemplares similares